Osteolytic bone disease is a frequent complication of multiple myeloma ... development of novel drugs for the management of lytic disease in myeloma. Currently, bisphosphonates are the mainstay ...

The team tackled a critical challenge in treating multiple myeloma—a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Multiple myeloma (MM) is a type of cancer that affects ... Deep learning techniques have also been applied to improve the detection of lytic bone lesions in CT scans. A study developed a two ...

Jan. 14, 2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients.

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Computed tomography (CT) is a sensitive tool for detection of the bone-destructive effects in MM as it can detect small osteolytic lesions ... is a hallmark of multiple myeloma (MM), associated ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...